Stockreport

Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease

CSL LTD SP/ADR  (CSLLY) 
NASDAQ:AMEX Investor Relations: csl.com/investors
PDF - The Agreement Covers Australia and New Zealand- Pharmanovia Will Take Over Rights From CSL Seqirus and Will Be Responsible for All Commercial and Regulatory Activities [Read more]